View Older Stories View More Recent Stories
-
Vistra prices $1.5B junior subordinated notes offering due 2057
-
Vistra Prices Registered Offering of $1.5 Billion of Junior Subordinated Notes
-
Capital Southwest prices $350M notes offering at 6.75% due 2031
-
Capital Southwest Corporation Prices Public Offering of $350 Million 6.750% Notes due 2031
-
Vistra launches junior subordinated notes offering to redeem preferred stock
-
Vistra Announces Registered Offering of Junior Subordinated Notes
-
RBC Capital on Microsoft (MSFT): 'Segment Refresh Brings Azure to Forefront'
-
RBC Capital on salesforce.com (CRM): 'All Eyes on Claudeforce, Reacceleration, and Long-Term Model'
-
Jersey Mike's Subs (JMKE) PT Raised to $29 at RBC Capital
-
Helmerich & Payne (HP) PT Raised to $49 at RBC Capital
-
Chewy Inc. (CHWY) PT Lowered to $31 at RBC Capital
-
Fullscript Announces Strategic Investment from Altas Partners and L Catterton
-
RBC Capital Downgrades BioCryst Pharma (BCRX) to Sector Perform
-
RBC Capital Upgrades PACCAR (PCAR) to Outperform
-
RBC Capital Upgrades Technip Energies NV (TE:FP) to Outperform
-
RBC Capital Starts StepStone Group (STEP) at Outperform
-
Fortis Inc. Announces Pricing of Fixed-to-Fixed Rate Junior Subordinated Notes
-
Oaktree Specialty Lending Corporation Prices Public Offering of $300,000,000 7.000% Notes due 2031
-
ENVESTNET TO ACQUIRE VESTMARK, EXTENDING ITS CAPABILITIES TO MEET THE ADVISOR MARKET'S GROWING DEMAND FOR INCREASINGLY SOPHISTICATED TRADING AND TAX SOLUTIONS
-
D.A. Davidson Expands Capital Advisory Capabilities with the Addition of Tim Meyer and Ted Speyer
-
Pharvaris B.V. (PHVS) PT Raised to $52 as RBC Capital Sees Upside
-
Evommune Inc (EVMN) PT Lowered to $21 at RBC Capital
-
Dyne Therapeutics (DYN) PT Lowered to $30 at RBC Capital Following NVS Setback
-
Casey's General Stores (CASY) PT Lowered to $910 at RBC Capital
-
Qualcomm (QCOM) PT Raised to $180; RBC Capital: 'AMZN deal a positive'
-
3 reasons why S&P 500 may drop up to 10% in the near term: RBC
-
Orion180 Insurance Group Inc. Announces Launch of Initial Public Offering
-
Independence Realty Trust and Centerspace agree to $8.1B all-stock merger
-
Independence Realty Trust and Centerspace to Merge in $8.1 Billion Combination
-
RBC Capital Starts Roche Holding (ROG:SW) (RHHBY) at Outperform
-
RBC Capital Starts Novartis (NOVN:SW) (NVS) at Sector Perform
-
RBC Capital Starts GlaxoSmithKline (GSK:LN) (GSK) at Sector Perform
-
RBC Capital Starts AstraZeneca (AZN:LN) (AZN) at Outperform
-
RBC Capital Starts Sanofi (SAN:FP) (SNY) at Sector Perform
-
First Hydrogen signs deal to acquire 60% stake in robotics IP firm
-
First Hydrogen Signs Definitive Agreement for Advanced Robotics Technology with Extensive IP and Prepares to Launch First Humanoid
-
Ares Capital prices $750M in unsecured notes due 2033
-
ARES CAPITAL CORPORATION PRICES PUBLIC OFFERING OF $750 MILLION 6.250% UNSECURED NOTES DUE 2033
-
RBC Capital on Neurocrine Bio. (NBIX): 'We like the setup and remain buyers'
-
RBC Capital: 'Can Colgate-Palmolive Company (CL) Remove the Plaque from the US Business?'
-
RBC Capital Reiterates Sector Perform Rating on Cencora Inc (COR)
-
VineBrook Homes Trust Announces Tender Offer for up to $30 million, or 909,090 Shares, of its Class A Common Stock
-
Sharon AI to Participate in Upcoming Investor Conferences
-
RBC Capital Upgrades Hub24 Ltd. (HUB:AU) to Outperform
-
RBC Capital Upgrades Netwealth Group Ltd. (NWL:AU) to Outperform
-
RBC Capital Upgrades Netwealth Group Ltd. (NWL:AU) to Outperform
-
RBC Capital Starts Shake Shack (SHAK) at Outperform
-
RBC Capital Downgrades AGF Management Ltd. (AGF/B:CN) (AGFMF) to Sector Perform
-
RBC Capital Downgrades Biohaven Pharma (BHVN) to Sector Perform
-
RBC Capital Downgrades Spire Healthcare (SPI:LN) (SRRHF) to Sector Perform
